Aleva Neurotherapeutics

Aleva Neurotherapeutics

Aleva Neurotherapeutics

Implantable Microelectrodes for Deep Brain Stimulation. Aleva Neurotherapeutics has developed a proprietary technology that enables significantly better therapies for a broad range of neurological diseases. They are designed to be more versatile, more precise and more efficient than currently available DBS approaches while causing fewer side effects and complications.

 

 

 

Fact

Estimated Annual Revenue of $9M

 

 

29 employees

57 mio $

raised funding

Other Success Stories